Fig. 1From: Effects of BNT162b2 mRNA vaccine on COVID-19 infection and hospitalisation amongst older people: matched case control study for EnglandNumbers of people in England who received their first COVID-19 vaccination dose between 8 December 2020 and 3 February 2021 by age group. The cumulative totals are relative to estimates of eligible population based on extracts from the National Health Application and Infrastructure Services (NHAIS) system as of the 15 November 2020. Prior to the 4 January 2021, all individuals received the BNT162b2 mRNA vaccine, after which individuals were vaccinated with either the BNT162b2 mRNA or ChAdOx1 adenovirus vector vaccinesBack to article page